Trademark Overview
On Wednesday, July 8, 2026, a trademark application was filed for NASHNEXT with the United States Patent and Trademark Office. The USPTO has given the NASHNEXT trademark a serial number of 99928816. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 8, 2026. This trademark is owned by GENFIT. The NASHNEXT trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable computer software platforms for for purchasing medical diagnostic tests, accessing laboratory test results, managing personal health information, communicating healthcare-related information between healthcare professionals and patients and supporting physician-directed identification of patients at risk; Downloadable clinical decision support software; Downloadable software for risk assessment and patient stratification
Providing medical information, consultancy and advisory services; Medical evaluation services for identifying patients at risk for metabolic disorders, liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Medical screening services for identifying patients at risk of MASH and liver fibrosis; Patient risk stratification services; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical information and medical consultancy and advisory services in the nature of clinical interpretation of biomarkers and assessment of the risk of liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined se...
